What question did this study set out to answer?

The aim is to evaluate the impact of surveillance on cancer stage and survival of cirrhotic patients diagnosed with hepatocellular carcinoma.

Semiannual and Annual Surveillance of Cirrhotic Patients for Hepatocellular Carcinoma: Effects on Cancer Stage and Patient Survival (Italian Experience)

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial examines cancer stage and patient survival in cirrhotic individuals, suggesting surveillance benefits.

The aim is to evaluate the impact of surveillance on cancer stage and survival of cirrhotic patients diagnosed with hepatocellular carcinoma.
Multicenter retrospective study involving 1051 patients with hepatocellular carcinoma.
Analyzed groups based on the timing of surveillance (semiannual vs. annual vs. symptomatic detection).
Survival adjusted for lead time across different stages of cirrhosis.
Cancer stage was less advanced in patients monitored semiannually and annually compared to those diagnosed symptomatically (p < 0.001).
Survival rates after 5 years were greater in groups under surveillance compared to symptomatic patients (p < 0.001).
Surveillance doubled the eligibility for liver transplantation candidates compared to symptomatic patients (68.5% vs. 32.3%, p < 0.001).

Trevisani et al. (2002) studied this question.

View Full Paper

Ask AI

Bookmark